Despite technological advances that improve solute clearance, patients on maintenance intermittent hemodialysis (IHD) continue to experience disproportionately high cardiovascular mortality. The conventional focus on clearance metrics alone fails to account for clinical observations linking dialysis sessions with recurrent cardiovascular and systemic injury. The reviewed work reframes this problem by examining the hemodynamic consequences of routine IHD and their downstream effects.
The authors introduce the term Repetitive Dialytic Stress Syndrome (RDSS) to encapsulate the idea that IHD is a repetitive iatrogenic stressor. RDSS describes how each dialysis session subjects the circulation and tissues to rapid physiologic perturbations, and how the cumulative effect of these perturbations over many sessions can drive subclinical and clinical organ injury. Considering IHD through the RDSS lens shifts emphasis from pure solute removal to the cumulative physiologic cost of treatment.
Key elements of the RDSS model are the rapid intradialytic changes in intravascular volume and plasma osmolarity. These abrupt shifts impose a cyclical hemodynamic burden on the cardiovascular system. The resulting instability can produce transient drops in tissue perfusion at the microcirculatory level. The review frames these recurrent, often subclinical, perfusion deficits as episodes of microcirculatory shock that are not captured by standard clearance-based adequacy measures.
Current evidence summarized in the article links these repetitive perfusion deficits to cycles of ischemia followed by reperfusion. This ischemia-reperfusion process generates a systemic injury cascade that extends beyond transient functional changes. Recurrent ischemia-reperfusion is proposed to be a unifying mechanism by which intradialytic hemodynamic disturbances cause ongoing inflammation, tissue injury, and progressive structural damage across multiple organs.
The review describes several organ systems affected by the RDSS cascade:
Heart: Recurrent intradialytic hypoperfusion is associated with myocardial stunning, which over time contributes to myocardial fibrosis and adverse cardiac remodeling.
Brain: Cyclical reductions in perfusion can produce cerebral white matter injury, with potential implications for cognitive function and cerebrovascular vulnerability.
Gut: Intermittent hypoperfusion of the splanchnic circulation may promote gut barrier dysfunction and endotoxemia, linking intradialytic hemodynamics to systemic inflammation.
Kidney: Recurrent hemodynamic stress is implicated in accelerated loss of residual kidney function among dialysis patients.
These manifestations are described as synchronous organ stunning arising from the same recurrent hemodynamic insult during IHD sessions.
A central recommendation of the article is to broaden the definition of dialysis adequacy to include measures of hemodynamic stability in addition to solute clearance. Framing IHD as RDSS supports the adoption of therapeutic strategies that prioritize physiological stability during treatment. Although specific interventions are not itemized in the abstract, the conceptual shift points to individualized approaches that reduce rapid intradialytic volume and osmolarity shifts, minimize episodes of intradialytic hypotension, and protect microcirculatory perfusion.
Emphasizing hemodynamic protection during dialysis could plausibly reduce the cumulative ischemia-reperfusion burden, limit progressive organ stunning, and improve long-term outcomes for patients on IHD.
The review argues that the clearance-focused paradigm is incomplete and that recognizing IHD as a repetitive hemodynamic stressor—RDSS—provides a mechanistic link between routine dialysis practice and multi-organ injury. Incorporating hemodynamic stability into dialysis adequacy metrics and clinical decision-making is presented as a strategic priority to mitigate RDSS. The abstract highlights the need for therapeutic strategies that optimize physiological stability to reduce repetitive ischemia-reperfusion injury and its sequelae.
Note: This summary is based solely on the article abstract and plain-language summary reported in the source. Detailed methodological data, specific therapeutic interventions, quantitative outcomes, and study-level evidence were not reported in the provided source text.